Agios Pharmaceuticals (AGIO) Treasury Shares (2012 - 2026)

Agios Pharmaceuticals' Treasury Shares history runs 15 years deep, the most recent figure standing at $16.2 million for Q1 2026.

• Quarterly Treasury Shares fell 99.9% year-over-year to $16.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.2 million (down 99.9% YoY) and the FY2025 annual result came in at $16.2 million, down 99.9% from the prior year.
• Treasury Shares was $802.5 million for Q1 2026 at Agios Pharmaceuticals, roughly flat from $802.5 million in the prior quarter.
• Across five years, Treasury Shares topped out at $802.5 million in Q1 2022 and bottomed at $802.5 million in Q1 2022.
• A 5-year average of $10.5 billion and a median of $16.2 billion in 2022 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2024 — Treasury Shares soared 99900.0% — and 2025, when it slumped 99.9%.
• Agios Pharmaceuticals' Treasury Shares stood at $802.5 million in 2022, then changed by 0.0% to $802.5 million in 2023, then changed by 0.0% to $802.5 million in 2024, then changed by 0.0% to $802.5 million in 2025, then changed by 0.0% to $802.5 million in 2026.
• Business Quant data shows AGIO's Treasury Shares at $802.5 million in Q1 2026, $802.5 million in Q4 2025, and $802.5 million in Q3 2025.